Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Pain, Postoperative 1Neuralgia 1Chronic Pain 1

Interventions

Morphine 7Ketamine 5Fentanyl 4Sodium Chloride 3Saline Solution 3Lidocaine 3Educational Status 3Dexmedetomidine 3Cognitive Behavioral Therapy 3Anesthetics, Local 3Surveys and Questionnaires 2Pregabalin 2Mindfulness-Based Stress Reduction 2Hypnosis 2Bupivacaine 2Botulinum Toxins, Type A 2Acetaminophen 26'-fluoro-4',9'-dihydro-N,N-dimethyl-4-phenylspiro(cyclohexane-1,1'(3'H)-pyrano(3,4-b)indol)-4-amine 2tianeptine 1siltuximab 1onabotulinum toxin A 1nabiximols 1morphine, naltrexone combination 1erenumab 1Yoga 1Waiting Lists 1Transcutaneous Electric Nerve Stimulation 1Tramadol 1Therapeutics 1Telemedicine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Chronic Pain × onabotulinum toxin A × Clear all
NCT04585620 2021-11-09

Botulinum Toxin A as Treatment for Chronic Postsurgical Pain Following Lung Cancer Surgery

Aalborg University Hospital

Phase 1/2 Unknown
30 enrolled

Neuralgia, Pain, Postoperative, Chronic Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡